1188095 C-9 C 9 An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chrétien Pledge to Africa) Loi modifiant la Loi sur les brevets et la Loi sur les aliments et drogues (engagement de Jean Chrétien envers l'Afrique) An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chrétien Pledge to Africa) 357 Royal assent received Sanction royale reçue Royal assent received 60046 Royal assent Sanction royale Royal assent Royal assent false 2 Senate Sénat Senate 60050 Royal assent Sanction royale Royal assent 60050 Royal assent Sanction royale Royal assent 2 Senate Sénat Senate 2004-05-14T10:06:00 37 3 3 House Government Bill Projet de loi émanant du gouvernement (Cdc) House Government Bill true 1 House of Commons Chambre des communes House of Commons true false 512 Lucienne Robillard Lucienne Robillard Hon. L'hon. Hon. Minister of Industry ministre de l'Industrie Minister of Industry 4 Minister ministre Minister 206 Westmount—Ville-Marie Westmount—Ville-Marie Westmount—Ville-Marie 60149 Royal assent Sanction royale 60050 Royal assent 2004-05-13T13:30:00 2 Senate Sénat Senate 0 0 42 Note concerning the date of Royal Assent: When the date of a written declaration differs from that of Royal Assent, the date shown in LEGISInfo corresponds to the date on which the two Houses of Parliament have been notified of the written declaration. Section 5 of the Royal Assent Act, S.C. 2002, c. 15, states: “Where royal assent is signified by written declaration, the Act is deemed to be assented to on the day on which the two Houses of Parliament have been notified of the declaration.” Note concernant la date de la sanction royale : En cas d’écart entre la date de la déclaration écrite et celle de la sanction royale, la date indiquée dans LEGISInfo correspond à la date à laquelle les deux chambres du Parlement ont été avisées de la déclaration écrite. L’article 5 de la Loi sur la sanction royale, L.C. 2002, ch. 15, se lit comme suit : « La déclaration écrite porte sanction royale le jour où les deux chambres du Parlement en ont été avisées. » Note concerning the date of Royal Assent: When the date of a written declaration differs from that of Royal Assent, the date shown in LEGISInfo corresponds to the date on which the two Houses of Parliament have been notified of the written declaration. Section 5 of the Royal Assent Act, S.C. 2002, c. 15, states: “Where royal assent is signified by written declaration, the Act is deemed to be assented to on the day on which the two Houses of Parliament have been notified of the declaration.” 2004-02-12T10:07:28 2004-02-12T10:30:00 2004-05-04T15:10:52 2004-05-04T00:00:00 2004-05-11T00:00:00 2004-05-13T00:00:00 2004-05-14T10:06:00 false false true true true true true true true false false 10 Regular Ordinaire Regular <div>Pursuant to Order made by the House of Commons on February 10, 2004, the Bill was deemed approved at all stages completed in the previous session (previously Bill C-56 in the 2nd Session of the 37th Parliament).</div> <div>Conformément à l'ordre adopté par la Chambre des communes le 10 février 2004, le projet de loi est réputé approuvé à toutes les étapes franchies lors de la session précédente (ancien projet de loi C-56 de la 2e session de la 37e législature).</div> <div>Pursuant to Order made by the House of Commons on February 10, 2004, the Bill was deemed approved at all stages completed in the previous session (previously Bill C-56 in the 2nd Session of the 37th Parliament).</div> true 2004 23 0 60029 First reading Première lecture First reading 1 37 3 4 Completed Terminée 2004-02-12T10:07:28 Completed Introduction and first reading Dépôt et première lecture Introduction and first reading 9 2004-02-12T00:00:00 true 60110 0 Introduction and first reading Dépôt et première lecture Introduction and first reading 2004-02-12T00:00:00 true false 60110 Introduction and first reading Dépôt et première lecture Introduction and first reading 2004-02-12T10:07:28 2004-02-12T10:07:28 1 2004-02-12T10:07:28 false false 60030 Second reading Deuxième lecture Second reading 1 37 3 4 Completed Terminée 2004-02-12T10:30:00 Completed 0 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST Standing Committee on Industry, Science and Technology 810500 6 false true false false Second reading and referral to committee Deuxième lecture et renvoi en comité Second reading and referral to committee 9 2004-02-12T00:00:00 true 808974 1191729 2nd reading and referral to committee - INST 2e lecture et renvoi en comité - INST 2nd reading and referral to committee - INST 15 Agreed To Adoptée Agreed To 2004-02-12T00:00:00 9 60121 0 Second reading and referral to committee Deuxième lecture et renvoi en comité Second reading and referral to committee 2004-02-12T00:00:00 true false 60121 Second reading and referral to committee Deuxième lecture et renvoi en comité Second reading and referral to committee 2004-02-12T10:30:00 2004-02-12T10:30:00 1 2004-02-12T10:30:00 false false 60049 Consideration in committee Examen en comité Consideration in committee 1 37 3 4 Completed Terminé 2004-04-23T12:37:36 Completed 0 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST Standing Committee on Industry, Science and Technology 810500 6 false true false false Committee report presented Présentation du rapport de comité Committee report presented 40 2004-04-23T00:00:00 true 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST 2 2004-02-24T00:00:00 Standing Committee on Industry, Science and Technology 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST 4 2004-02-26T00:00:00 Standing Committee on Industry, Science and Technology 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST 5 2004-03-09T00:00:00 Standing Committee on Industry, Science and Technology 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST 6 2004-03-10T00:00:00 Standing Committee on Industry, Science and Technology 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST 7 2004-03-11T00:00:00 Standing Committee on Industry, Science and Technology 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST 10 2004-04-20T00:00:00 Standing Committee on Industry, Science and Technology 8794 Standing Committee on Industry, Science and Technology Comité permanent de l'industrie, des sciences et de la technologie INST 11 2004-04-22T00:00:00 Standing Committee on Industry, Science and Technology 60124 0 Committee report presented Présentation du rapport de comité Committee report presented 2004-04-23T00:00:00 true false 1301702 1 60124 Committee report presented Présentation du rapport de comité Committee report presented 2004-04-23T12:37:36 2004-04-23T12:37:36 1 2004-04-23T12:37:36 false false 60032 Report stage Étape du rapport Report stage 1 37 3 4 Completed Terminée 2004-04-28T18:00:44 Completed Debate at report stage Débat à l’étape du rapport Debate at report stage 43 2004-04-28T00:00:00 true 60285 0 Concurrence at report stage with further amendments Adoption à l’étape du rapport avec d'autres amendements Concurrence at report stage with further amendments 2004-04-28T00:00:00 true false 60285 Concurrence at report stage Adoption à l’étape du rapport Concurrence at report stage 2004-04-28T18:00:44 2004-04-28T18:00:44 1 2004-04-28T18:00:44 false false 60031 Third reading Troisième lecture Third reading 1 37 3 4 Completed Terminée 2004-05-04T15:10:52 Completed Debate at third reading Débat à l’étape de la troisième lecture Debate at third reading 44 2004-04-29T00:00:00 true Third reading Troisième lecture Third reading 47 2004-05-04T00:00:00 true 60134 0 Third reading Troisième lecture Third reading 2004-05-04T00:00:00 true false 60134 Third reading Troisième lecture Third reading 2004-05-04T15:10:52 2004-05-04T15:10:52 1 2004-05-04T15:10:52 false false 60029 First reading Première lecture First reading 2 37 3 4 Completed Terminée 2004-05-04T00:00:00 Completed First reading Première lecture First reading 36 2004-05-04T00:00:00 false 60111 0 First reading Première lecture First reading 2004-05-04T00:00:00 true false 60111 First reading Première lecture First reading 2004-05-04T00:00:00 2004-05-04T00:00:00 1 2004-05-04T00:00:00 false false 60030 Second reading Deuxième lecture Second reading 2 37 3 4 Completed Terminée 2004-05-11T00:00:00 Completed 0 16098 Standing Senate Committee on Foreign Affairs and International Trade Comité sénatorial permanent des affaires étrangères et du commerce international AEFA Standing Senate Committee on Foreign Affairs and International Trade false true false false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 38 2004-05-06T00:00:00 false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 39 2004-05-10T00:00:00 false Debate at second reading Débat à l’étape de la deuxième lecture Debate at second reading 40 2004-05-11T00:00:00 false 60120 0 Second reading Deuxième lecture Second reading 2004-05-11T00:00:00 true false 60123 0 Referral to committee Renvoi en comité Referral to committee 2004-05-11T00:00:00 true false 60120 Second reading Deuxième lecture Second reading 2004-05-11T00:00:00 2004-05-11T00:00:00 1 2004-05-11T00:00:00 0 2 60152 Sponsor’s speech Discours du parrain Sponsor’s speech 0 37 3 38 2004-05-06T00:00:00 https://sencanada.ca/en/content/sen/chamber/373/debates/038db_2004-05-06-e#40 https://sencanada.ca/fr/content/sen/chamber/373/debates/038db_2004-05-06-f#40 https://sencanada.ca/en/content/sen/chamber/373/debates/038db_2004-05-06-e#40 0 2 60153 Response speech Discours en réponse Response speech 0 37 3 38 2004-05-06T00:00:00 https://sencanada.ca/en/content/sen/chamber/373/debates/039db_2004-05-10-e#44 https://sencanada.ca/fr/content/sen/chamber/373/debates/039db_2004-05-10-f#44 https://sencanada.ca/en/content/sen/chamber/373/debates/039db_2004-05-10-e#44 true false 60049 Consideration in committee Examen en comité Consideration in committee 2 37 3 4 Completed Terminé 2004-05-13T00:00:00 Completed 0 16098 Standing Senate Committee on Foreign Affairs and International Trade Comité sénatorial permanent des affaires étrangères et du commerce international AEFA Standing Senate Committee on Foreign Affairs and International Trade false true false false Committee report presented Présentation du rapport de comité Committee report presented 42 2004-05-13T00:00:00 false 16098 Standing Senate Committee on Foreign Affairs and International Trade Comité sénatorial permanent des affaires étrangères et du commerce international AEFA 10 2004-05-12T00:00:00 Standing Senate Committee on Foreign Affairs and International Trade 60124 0 Committee report presented Présentation du rapport de comité Committee report presented 2004-05-13T00:00:00 true false 60124 Committee report presented Présentation du rapport de comité Committee report presented 2004-05-13T00:00:00 2004-05-13T00:00:00 1 2004-05-13T00:00:00 false false 60031 Third reading Troisième lecture Third reading 2 37 3 4 Completed Terminée 2004-05-13T00:00:00 Completed Debate at third reading Débat à l’étape de la troisième lecture Debate at third reading 42 2004-05-13T00:00:00 false 60134 0 Third reading Troisième lecture Third reading 2004-05-13T00:00:00 true false 60134 Third reading Troisième lecture Third reading 2004-05-13T00:00:00 2004-05-13T00:00:00 1 2004-05-13T00:00:00 false false 60050 Royal assent Sanction royale Royal assent 2 37 3 0 Royal assent Sanction royale Royal assent 42 2004-05-13T00:00:00 false 60149 0 Royal assent Sanction royale Royal assent 2004-05-14T10:06:00 true false Note concerning the date of Royal Assent: When the date of a written declaration differs from that of Royal Assent, the date shown in LEGISInfo corresponds to the date on which the two Houses of Parliament have been notified of the written declaration. Section 5 of the Royal Assent Act, S.C. 2002, c. 15, states: “Where royal assent is signified by written declaration, the Act is deemed to be assented to on the day on which the two Houses of Parliament have been notified of the declaration.” Note concernant la date de la sanction royale : En cas d’écart entre la date de la déclaration écrite et celle de la sanction royale, la date indiquée dans LEGISInfo correspond à la date à laquelle les deux chambres du Parlement ont été avisées de la déclaration écrite. L’article 5 de la Loi sur la sanction royale, L.C. 2002, ch. 15, se lit comme suit : « La déclaration écrite porte sanction royale le jour où les deux chambres du Parlement en ont été avisées. » Note concerning the date of Royal Assent: When the date of a written declaration differs from that of Royal Assent, the date shown in LEGISInfo corresponds to the date on which the two Houses of Parliament have been notified of the written declaration. Section 5 of the Royal Assent Act, S.C. 2002, c. 15, states: “Where royal assent is signified by written declaration, the Act is deemed to be assented to on the day on which the two Houses of Parliament have been notified of the declaration.” 60149 Royal assent Sanction royale Royal assent 2004-05-14T10:06:00 2004-05-14T10:06:07 1 2004-05-14T10:06:00 false false 2331617 80701 First Reading Première lecture First Reading 2331618 80702 As amended by committee Tel que modifié par le comité As amended by committee 2331619 80703 As passed by the House of Commons Tel qu’adopté par la Chambre des communes As passed by the House of Commons 2331620 80704 Royal Assent Royal Assent Royal Assent 0 Export of generic medicines to developing countries (Canadian HIV/AIDS Legal Network) Exportation de médicaments génériques vers des pays en développement (Réseau juridique canadien VIH/sida) Export of generic medicines to developing countries (Canadian HIV/AIDS Legal Network) 8 Related Links Liens connexes Related Links 0 UN RIGHTS EXPERT WELCOMES CANADIAN INITIATIVE ON ACCESS TO LOW-COST DRUGS IN DEVELOPING COUNTRIES (United Nations Press Release) UN EXPERT DE L'ONU SALUE L'INITIATIVE CANADIENNE SUR L'ACCÈS AUX MÉDICAMENTS À PRIX MODIQUE DANS LES PAYS EN DÉVELOPPEMENT (Communiqué de presse, Nations Unies) UN RIGHTS EXPERT WELCOMES CANADIAN INITIATIVE ON ACCESS TO LOW-COST DRUGS IN DEVELOPING COUNTRIES (United Nations Press Release) 8 Related Links Liens connexes Related Links 0 Prime Minister’s statement on amendments to Bill C-9, The Jean Chrétien Pledge To Africa Act (Office of the Prime Minister) Déclaration du Premier ministre sur les amendements au projet de loi C-9, Loi de l'engagement de Jean Chrétien envers l'Afrique (Cabinet du Premier Ministre) Prime Minister’s statement on amendments to Bill C-9, The Jean Chrétien Pledge To Africa Act (Office of the Prime Minister) 8 Related Links Liens connexes Related Links 0 Government of Canada Moving Forward with Legislation to Improve Access to Medicines in Developing Countries (Industry Canada) Le gouvernement du Canada va de l'avant avec un projet de loi visant à améliorer l'accès aux médicaments dans les pays en développement (Industrie Canada) Government of Canada Moving Forward with Legislation to Improve Access to Medicines in Developing Countries (Industry Canada) 8 Related Links Liens connexes Related Links 0 331 Out-licensing: a practical approach for improvement of access to medicines in poor countries Friedman, Michael A., Henk den Besten and Amir Attaran The Lancet 361:341-44 Jan. 25, 2003 R31 L36 1 false 0 332 Protection racket: drugs companies are tightening their hold on Third World markets MacKenzie, Debora New scientist 171:18-19 Jul. 21, 2003 Q1 N52 1 false 0 333 Experts clash over liklely impact of cheap AIDS drugs in Africa Wadman, Meredith Nature 410:615-16 Apr. 5, 2001 Q1 N38 1 false 0 334 A war over drugs and patents The Economist 358:43-4 Mar. 10, 2001 HG11 E26 1 false 0 335 Drug-induced dilemma The Economist 359:59-60 Apr. 21, 2001 HG11 E26 1 false 0 336 Symptomatic relief: drugs, patents and the WTO The Economist 368:13 Sept. 6, 2003 HG11 E26 1 false 0 1033 Intellectual property and the AIDS pandemic Kossick, Don Briar patch 35:12-15 Dec. 2006/Jan. 2007 HC111 B75 1 false 0 1033 Intellectual property and the AIDS pandemic Kossick, Don Briar patch 35:12-15 Dec. 2006/Jan. 2007 HC111 B75 1 false 0 816 Medicines for the developing world: promoting access and innovation in the post-TRIPS environment Morgan, Maxwell R University of Toronto Faculty of Law review 64:45-111 Winter 2006 K25 N54 3 false 0 386 Intellectual property - patents and copyright Hore, Ed Canadian lawyer 28:31, 33 Feb. 2004 K3 A494 1 false 0 389 Accès des pays pauvres aux soins et aux médicaments : un espoir enfin? Lethu, Thérèse Problèmes économiques no 2722:10-13 18 juil. 2001 D411 F81 2 false 0 395 FTAA [Free Trade Agreement of the Americas] could interfere with proposed Canadian patent legislation allowing generic exports Silversides, Ann CMAJ:Canadian Medical Association journal 170:937 Mar. 16, 2004 R11 C36 1 false 0 424 New free trade agreement could make generic drugs less accessible in the Americas Silversides, Ann CMAJ: Canadian Medical Association journal 170:935, 937 Mar. 16, 2004 R11 C35 1 false 0 491 Distributive politics and international institutions: the case of drugs Benvenisti, Eyal and George W. Downs Case Western Reserve journal of international law 36:21-51 Winter 2004 JX1 C38 1 false 0 337 The G8 fails global health Orbinski, James CMAJ:Canadian Medical Association journal 167:481-2 Sept. 3, 2002 R11 C36 1 false 0 338 In Africa, patents kill Shulman, Seth Technology review 104:37 Apr. 2001 PNC 1 false 0 339 No turning back on cheap AIDS drugs for poor nations, UN vows Silversides, Anne CMAJ:Canadian Medical Association journal 169:1067 Nov. 11, 2003 R11 C36 2 false 0 344 The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS Curti, Andrea M. American journal of law and medicine 27:469-85 no. 4 2001 1 false 0 354 Martin government to reintroduce patent changes Eggertson, Laura CMAJ:Canadian Medical Association journal 170:456 Feb. 17, 2004 R11 C36 1 false 0 385 Hold-up sur le médicament Velasquez, German Le Monde diplomatique no 592:1, 26-7 juil 2003 JX3 M66 2 false 1151850 C-56 C 56 An Act to amend the Patent Act and the Food and Drugs Act Loi modifiant la Loi sur les brevets et la Loi sur les aliments et drogues An Act to amend the Patent Act and the Food and Drugs Act 352 At consideration in committee in the House of Commons À l'examen en comité à la Chambre des communes At consideration in committee in the House of Commons 60044 Second reading Deuxième lecture Second reading Second reading in the House of Commons false 1 0 60030 Second reading Deuxième lecture Second reading 1 House of Commons Chambre des communes House of Commons 2003-11-07T13:55:00 37 2 0 House Government Bill Projet de loi émanant du gouvernement (Cdc) House Government Bill false 1 true false 0 0001-01-01T00:00:00 0 0 0 2003-11-06T10:31:50 2003-11-07T13:55:00 false false true true false false false false false false false 0 false 0 false false false false